Completed
These studies have finished collecting, analyzing, and reporting data and are now archived.
-
CTNPT 013: Sexual health and HIV-risk management in MSM
The impact of in-clinic follow-up with a sexologist on the sexual health of HIV-serodiscordant MSM couples
-
CTN 283: the I-Score Study
The development and validation of a patient-reported measure of antiretroviral therapy’s interference with life: a clinical patient-management tool for healthcare providers
-
-
CTN 239: Phase II study of AGS-004 an immunotherapeutic agent in combination with ART followed by ART interruption
A phase II study testing the activity and safety of AGS-004 as an immunotherapeutic in successfully ART-treated subjects infected with HIV-1 in combination with ART followed by ART interruption: Trial results
-
CTN 268: ANRS IPERGAY trial
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
-
CTN 229: Effect of AGS-004 immunotherapeutic agent in HIV-positive people on HAART
A pilot study (Phase I/II) testing the immunologic activity and safety of AGS-004, an autologous HIV immunotherapeutic, in HIV-infected adults on HAART: Trial results
-
CTN 256: Phase IIB study of efficacy and safety of AGS-004
A randomized, double blind, phase IIB study testing the efficacy and safety of AGS-004 on host control of HIV replication during analytical treatment interruption: Trial results
-
CTNPT 008: HIV quit smoking pilot study
Counselling programme in combination with nicotine replacement therapy
-
CTNPT 017: Valacyclovir for Inflammation Attenuation Trial Pilot (VALIANT Pilot)
Can valacylovir attenuate inflammation in ART-treated HIV-infected individuals with herpes simplex virus type 2? Trial results
-
CTNPT 026: Neuroimaging as a biomarker for cognitive training in HAND
Brain imaging to understand HIV-associated neurocognitive disorder and predict response to cognitive training
-
CTNPT 006: The Niaspan® study
Role of extended-released niacin on immune activation in HIV-infected patients treated with antiretroviral therapy: a proof-of-concept study
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.v
Learn More